Arterenol bitartrate stands out in the chemical landscape as a vital raw material in both pharmaceutical and research fields. Known in scientific circles as norepinephrine bitartrate, this compound earns attention for its importance as a neurotransmitter and hormone, actively shaping responses related to stress and cardiovascular function. A look at the white, crystalline appearance signals purity that’s expected for a substance involved in precise medical settings. Many reference its close association with medical interventions, especially in emergency care, but its physical characteristics also create distinct expectations for how it behaves during handling, storage, and processing.
Scientists describe arterenol bitartrate by its molecular formula C8H11NO3·C4H6O6 and a molecular weight that sits around 329.3 g/mol. Its crystalline solid form makes it practical to dose, measure, and transport. The compound carries a density characteristic that's commonly cited near 1.5 g/cm3, which aligns with its flake or powdery appearance. In most lab environments, it appears as a solid, though under specific conditions, workers dissolve it in aqueous solutions for accurate dosing or chemical reactions. Chemists see arterenol bitartrate either as neat crystals, flakes, or in a finely ground powder state. Handling this chemical means paying close attention to its hygroscopic nature—the way it tends to absorb moisture from the air, requiring solid packaging and thoughtfully controlled storage. Left open, this material clumps and degrades; experienced lab staff know this from frustrating, expensive loss if protocols slip.
Looking at the chemical structure shines a light on why arterenol bitartrate acts as it does. The molecule integrates the catecholamine backbone—two hydroxyl groups on a benzene ring plus an amine—and this gives it its biological punch. The tartaric acid salt form, bitartrate, stabilizes the molecule, making shipping viable and allowing for accurate dosing by weight rather than relying on variable liquid concentrations. Internationally, this compound falls under the HS Code 292219, marking it for trade and customs purposes. Knowing this code streamlines global movement, reporting, and compliance with regulatory bodies. In my work with customs documentation for specialty chemicals, the value of correct HS coding can’t be overstated; delays from mismatches cost both time and customer faith.
Most labs store arterenol bitartrate in containers that keep out excess light and moisture, since the solid turns sticky or degrades under poor conditions. Open a new bottle and it pours as a fine, white or slightly off-white powder—or sometimes as delicate crystalline flakes, depending on synthesis route and drying style at the factory. Occasionally, it appears as pearl-like grains. The visual cues—the way it shimmers under a light, the texture as a scoopful pours out—signal to an experienced chemist if something went wrong during manufacturing or shipment. Density feels apparent when you fill a graduated cylinder, helping calibrate exact solutions for lab use.
Arterenol bitartrate’s structure enables quick dissolution in water for applications that demand accuracy in low concentrations, such as dose preparation in clinical settings. The compound’s stability and controlled crystallinity mean a chemist can depend on it for consistent results—a lesson I recall from earlier days of troubleshooting erratic yields when a batch stored improperly proved unreliable. Recognizing patterns in how the material behaves provides early warning for compromised shipments or accidental contamination, supporting the core principle of safety in chemical handling.
Behind the promise of practical medical impact, arterial bitartrate demands respect in handling. Classified as harmful if inhaled, swallowed, or absorbed through skin, it signals its potential for acute toxicity to humans. It’s hazardous in raw form; gloves, goggles, and protective coats aren’t up for negotiation. I’ve seen what happens when basic protocols lapse: an employee complains of dizziness and palpitations after accidental skin exposure. A chemical like this, with cardiovascular effects in minute doses, brings potential for harm even in nonclinical environments. Poor ventilation or careless transfer from storage—scattered powder or spilled solution—poses significant risk. Safety Data Sheets outline these dangers, but the lesson that sticks comes from personal involvement in a near-miss. Immediate isolation and neutralization procedures, access to running water for decontamination, and strict compliance with chemical disposal standards all become everyday practice.
Pharmaceutical manufacturers use arterenol bitartrate as a foundational material for synthesizing both active therapeutic agents and intermediates. Its sensitivity to environmental conditions and risk profile mean that supply-chain partners must agree on exact specifications for purity, moisture content, and container style. From managing cold-chain logistics for stability to regular auditing of supplier batches, every link in the chain understands the economic and patient safety stakes. On the front lines, some labs use smaller pre-weighed capsules to cut down on accidental exposure during weighing, while newer airless packaging technology addresses the moisture problem that can ruin entire stocks. Investments in staff training lead directly to fewer accidents. Daunting as those dangers seem, seeing these practices adopted reduces the likelihood of lost product—and more importantly, keeps all involved safe. This is the lived reality for anyone handling material with such pronounced effects and sensitive traits.
Arterenol bitartrate presents as a white to off-white crystalline powder or flakes, soluble in water but less in organic solvents. Molecular formula is C8H11NO3·C4H6O6. Average molecular weight measures about 329.3 g/mol, with density near 1.5 g/cm3. Common forms include solid flakes, powder, or more rarely, pearl-like crystals. HS Code 292219 governs commerce of this compound. Handling requires strict use of PPE due to hazardous potential—the chemical acts as a strong cardiovascular agent and carries toxic risk. Known primarily as a raw material in the pharmaceutical sector, arterenol bitartrate demands all handlers respect its power and follow evidence-based protocols for storage, measurement, and disposal.